» Articles » PMID: 1689542

The Neuroendocrine and Neural Profiles of Neuroblastomas, Ganglioneuroblastomas, and Ganglioneuromas

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 1990 Feb 1
PMID 1689542
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

To establish the neuroendocrine and neural features of peripheral neuroblastic tumors, a prospectively collected group of 12 neuroblastomas (NB), 2 ganglioneuroblastomas (GNB), and 4 ganglioneuromas (GN) was probed with a panel of monoclonal antibodies (MAbs) to neuroendocrine and neural antigens. All tumors expressed the pan-neuroendocrine markers synaptophysin and chromogranin A. They also showed extensive expression of neuronal antigens, ie, of each of the neurofilament (NF) triplet proteins and of the microtubule-associated proteins (MAPs) MAP2 and tau-protein. However, only in the GNBs and GNs was the pattern of NF phosphoisoforms relatively mature. In the latter tumors glial fibrillary acidic protein (GFAP) and myelin basic protein (MBP) could be demonstrated as well, suggesting the presence of nonmyelinating and myelinating Schwann cells, respectively. The glial markers did not colocalize with the neural markers. On the basis of these data, it was concluded that all peripheral neuroblastic tumors manifest molecular characteristics of neuroendocrine cells and of neurons. The latter were most developed in GNBs and GNs, in which they were accompanied by Schwann cell differentiation in a separate population of cells. The above-outlined neuronal profile of peripheral neuroblastic tumors, including NBs, distinguishes this group of tumors from the much-less neuronally differentiated primitive neuroectodermal tumors of the central nervous system.

Citing Articles

Nerve Density and Neuronal Biomarkers in Cancer.

Ali S, Jordan M, Nagarajan P, Amit M Cancers (Basel). 2022; 14(19).

PMID: 36230740 PMC: 9561962. DOI: 10.3390/cancers14194817.


Expression of Microtubule-Associated Proteins in Relation to Prognosis and Efficacy of Immunotherapy in Non-Small Cell Lung Cancer.

Luo J, Hu Q, Gou M, Liu X, Qin Y, Zhu J Front Oncol. 2021; 11:680402.

PMID: 34660263 PMC: 8517487. DOI: 10.3389/fonc.2021.680402.


Synaptic Vesicle Protein 2 and Vesicular Monoamine Transporter 1 and 2 Are Expressed in Neuroblastoma.

Georgantzi K, Tsolakis A, Jakobson A, Christofferson R, Janson E, Grimelius L Endocr Pathol. 2019; 30(3):173-179.

PMID: 31317476 DOI: 10.1007/s12022-019-09584-3.


Surgical Excision of an Adrenal Neuroblastoma in a Dog.

Mestrinho L, Marques M, Jesus S, Pissarra H, Peleteiro M, Ferreira A Front Vet Sci. 2019; 6:161.

PMID: 31214604 PMC: 6555272. DOI: 10.3389/fvets.2019.00161.


Favorable prognostic role of tropomodulins in neuroblastoma.

Bettinsoli P, Ferrari-Toninelli G, Bonini S, Guarienti M, Cangelosi D, Varesio L Oncotarget. 2018; 9(43):27092-27103.

PMID: 29930753 PMC: 6007461. DOI: 10.18632/oncotarget.25491.


References
1.
Dehner L . Peripheral and central primitive neuroectodermal tumors. A nosologic concept seeking a consensus. Arch Pathol Lab Med. 1986; 110(11):997-1005. View

2.
Tischler A, Dichter M, Biales B, Greene L . Neuroendocrine neoplasms and their cells of origin. N Engl J Med. 1977; 296(16):919-25. DOI: 10.1056/NEJM197704212961608. View

3.
Hoog A, Gould V, Grimelius L, Franke W, Falkmer S, Chejfec G . Tissue fixation methods alter the immunohistochemical demonstrability of synaptophysin. Ultrastruct Pathol. 1988; 12(6):673-8. DOI: 10.3109/01913128809056493. View

4.
Deftos L, Linnoila R, Carney D, Burton D, Leong S, OConnor D . Demonstration of Chromogranin A in human neuroendocrine cell lines by immunohistology and immunoassay. Cancer. 1988; 62(1):92-7. DOI: 10.1002/1097-0142(19880701)62:1<92::aid-cncr2820620117>3.0.co;2-t. View

5.
Black M, Lee V . Phosphorylation of neurofilament proteins in intact neurons: demonstration of phosphorylation in cell bodies and axons. J Neurosci. 1988; 8(9):3296-305. PMC: 6569427. View